Page last updated: 2024-10-29

indomethacin and Duodenal Diseases

indomethacin has been researched along with Duodenal Diseases in 6 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Duodenal Diseases: Pathological conditions in the DUODENUM region of the small intestine (INTESTINE, SMALL).

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Singh, M1
Reichert, P1
Cann, H1
Meddings, JB1
Sutherland, LR1
Byles, NI1
Wallace, JL1
Stalnikowicz, R2
Goldin, E2
Fich, A2
Wengrower, D2
Eliakim, R1
Ligumsky, M2
Rachmilewitz, D2
Pollak, D1
Eliakim, A1
Müller, P1
Dammann, HG1
Simon, B1
Ewing, GO1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
GpCRC Pediatric Gastroparesis Registry 2: Characterization and Clinical Course of Symptoms and Gastric Emptying in Pediatric, Adolescent, and Young Adult Participants With Symptoms of Gastroparesis[NCT05981300]216 participants (Anticipated)Observational [Patient Registry]2024-02-28Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

3 trials available for indomethacin and Duodenal Diseases

ArticleYear
Indomethacin-induced gastroduodenal damage is not affected by cotreatment with ranitidine.
    Journal of clinical gastroenterology, 1989, Volume: 11, Issue:2

    Topics: Adolescent; Adult; Aged; Double-Blind Method; Drug Synergism; Duodenal Diseases; Duodenum; Female; G

1989
Cimetidine decreases indomethacin induced duodenal mucosal damage in patients with acute musculoskeletal disorders.
    Gut, 1988, Volume: 29, Issue:11

    Topics: Adolescent; Adult; Aged; Bone Diseases; Cimetidine; Clinical Trials as Topic; Double-Blind Method; D

1988
[Gastroduodenal tolerability of indomethacin and acetaminophen. A comparative endoscopic study in healthy subjects].
    Arzneimittel-Forschung, 1986, Volume: 36, Issue:2

    Topics: Acetaminophen; Adult; Double-Blind Method; Drug Tolerance; Duodenal Diseases; Gastric Mucosa; Gastro

1986

Other Studies

3 other studies available for indomethacin and Duodenal Diseases

ArticleYear
Abrupt onset of abdominal pain. Duodenal perforation caused by indomethacin.
    The Journal of family practice, 2013, Volume: 62, Issue:12

    Topics: Abdominal Pain; Anti-Inflammatory Agents, Non-Steroidal; Duodenal Diseases; Humans; Indomethacin; In

2013
Sucrose: a novel permeability marker for gastroduodenal disease.
    Gastroenterology, 1993, Volume: 104, Issue:6

    Topics: Animals; Duodenal Diseases; Duodenum; Gastric Mucosa; Humans; Indomethacin; Male; Permeability; Rabb

1993
Indomethacin-associated gastrointestinal hemorrhage in a dog.
    Journal of the American Veterinary Medical Association, 1972, Dec-15, Volume: 161, Issue:12

    Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Duodenal Diseases; Female; Gastritis; Gastrointes

1972